Adjuvant Biophysical Therapies in Osteosarcoma
- PMID: 30871044
- PMCID: PMC6468347
- DOI: 10.3390/cancers11030348
Adjuvant Biophysical Therapies in Osteosarcoma
Abstract
Osteosarcoma (OS) is a primary bone sarcoma, manifesting as osteogenesis by malignant cells. Nowadays, patients' quality of life has been improved, however continuing high rates of limb amputation, pulmonary metastasis and drug toxicity, remain unresolved issues. Thus, effective osteosarcoma therapies are still required. Recently, the potentialities of biophysical treatments in osteosarcoma have been evaluated and seem to offer a promising future, thanks in this field as they are less invasive. Several approaches have been investigated such as hyperthermia (HT), high intensity focused ultrasound (HIFU), low intensity pulsed ultrasound (LIPUS) and sono- and photodynamic therapies (SDT, PDT). This review aims to summarize in vitro and in vivo studies and clinical trials employing biophysical stimuli in osteosarcoma treatment. The findings underscore how the technological development of biophysical therapies might represent an adjuvant role and, in some cases, alternative role to the surgery, radio and chemotherapy treatment of OS. Among them, the most promising are HIFU and HT, which are already employed in OS patient treatment, while LIPUS/SDT and PDT seem to be particularly interesting for their low toxicity.
Keywords: adjuvant therapies; biophysical stimuli; osteosarcoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.Oncotarget. 2017 Jun 13;8(24):39833-39848. doi: 10.18632/oncotarget.16243. Oncotarget. 2017. PMID: 28418855 Free PMC article. Review.
-
Inhibitory effects of low-intensity pulsed ultrasound sonication on the proliferation of osteosarcoma cells.Oncol Lett. 2017 Sep;14(3):3071-3076. doi: 10.3892/ol.2017.6472. Epub 2017 Jun 23. Oncol Lett. 2017. PMID: 28928844 Free PMC article.
-
Acridine orange inhibits pulmonary metastasis of mouse osteosarcoma.Anticancer Res. 2011 Dec;31(12):4163-8. Anticancer Res. 2011. PMID: 22199275
-
Synergistic interaction of 5-aminolevulinic acid-based photodynamic therapy with simultaneous hyperthermia in an osteosarcoma tumor model.Int J Oncol. 2006 Aug;29(2):365-73. Int J Oncol. 2006. PMID: 16820878
-
High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma.Surg Oncol. 2015 Mar;24(1):9-15. doi: 10.1016/j.suronc.2014.10.001. Epub 2014 Nov 14. Surg Oncol. 2015. PMID: 25453577 Review.
Cited by
-
Perspective Applications and Associated Challenges of Using Nanocellulose in Treating Bone-Related Diseases.Front Bioeng Biotechnol. 2021 May 7;9:616555. doi: 10.3389/fbioe.2021.616555. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34026739 Free PMC article. Review.
-
Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980769. doi: 10.1177/1533033820980769. Technol Cancer Res Treat. 2020. PMID: 33308057 Free PMC article.
-
Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4+ T-cell differentiation.Cancer Immunol Immunother. 2024 Jan 18;73(1):15. doi: 10.1007/s00262-023-03590-5. Cancer Immunol Immunother. 2024. PMID: 38236243 Free PMC article.
-
RNF219/α-Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications.Adv Sci (Weinh). 2020 Dec 31;8(4):2001961. doi: 10.1002/advs.202001961. eCollection 2021 Feb. Adv Sci (Weinh). 2020. PMID: 33643786 Free PMC article.
-
Mild hyperthermia by MR-guided focused ultrasound in an ex vivo model of osteolytic bone tumour: optimization of the spatio-temporal control of the delivered temperature.J Transl Med. 2019 Oct 24;17(1):350. doi: 10.1186/s12967-019-2094-x. J Transl Med. 2019. PMID: 31651311 Free PMC article.
References
-
- Bielack S., Kempf-Bielack B., Von Kalle T., Schwarz R., Wirth T., Kager L., Whelan J. Controversies in childhood osteosarcoma. Minerva Pediatr. 2013;65:125–148. - PubMed
-
- Bielack S.S., Kempf-Bielack B., Delling G., Exner G.U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Werner M., Winkelmann W., et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2002;20:776–790. doi: 10.1200/JCO.2002.20.3.776. - DOI - PubMed
-
- Kager L., Zoubek A., Pötschger U., Kastner U., Flege S., Kempf-Bielack B., Branscheid D., Kotz R., Salzer-Kuntschik M., Winkelmann W., et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J. Clin. Oncol. 2003;21:2011–2018. doi: 10.1200/JCO.2003.08.132. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources